Carotenoid oxidative degradation products inhibit Na+-K+-ATPase

Free Radical Research

Volumn 33, Issue 4, 2000, Pages 427-435

  Siems, Werner G ^a,b   Sommerburg, Olaf ^a,c   Hurst, John S ^a   Van Kuijk, Frederik J G M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Herzog Julius Klinik GmbH & Co KG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

4 hydroxynonenal; Aldehydes; Carotenoid breakdown products; Carotenoids; Na+ K+ ATPase

Indexed keywords

4 HYDROXYNONENAL; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDEHYDE; BETA CAROTENE; CAROTENOID; HYDROXYLAMINE; HYPOCHLOROUS ACID; MERCAPTOETHANOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; LIPID PEROXIDATION; NONHUMAN; OXIDATION; TOXICITY;

ANIMALIA;

EID: 0033807264     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760000300961     Document Type: Article

References (58)

1. Carotenoid protection against oxidation
2. β-Carotene: An unusual type of lipid antioxidant
3. Antioxidant functions of vitamins. Vitamins E and C, b-carotene, and other carotenoids
4. Antioxidant reactions of carotenoids
5. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration
6. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers
7. Beta-carotene, carotenoids, and disease prevention in humans
8. β-Carotene: Friend or foe?
9. Co-carcinogenic effect of β-carotene
10. β-Apo-8'-carotenal, but not β-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat
11. Carotenoid metabolites as cell signaling modulators
12. Characterization of products formed during the autoxidation of β-carotene
13. +-ATPase
14. Inhibition of NADPH oxidase-mediated superoxide radical formation in PMA-stimulated human neutrophils by 4-hydroxynonenal binding to -SH and -NH2 groups
15. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal
16. Selective cleavage of thioether linkage in proteins modified with 4-hydroxynonenal
17. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxynonenal: Selective modification of an active-site lysine
18. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase: A possible involvement of intra- and intermolecular cross-linking reaction
19. Dose- and wavelength-dependent oxidation of crystallins by UV light-selective recognition and degradation by the 20S proteasome
20. Synthesis of deuterated 4-hydroxy-alkenals
21. Relative solubility, stability, and absorptivity of lutein and β-carotene in organic solvents
22. Simultaneous detection of carotenoids and vitamin E in human plasma
23. Rapid analysis of the major classes of retinoid by step gradient reversed-phase high performance liquid chromatography using retinal (O-ethyl) oxime derivatives
24. +)-activated ATPase, XLII: Evidence for two classes of essential sulhydryl groups
25. Phosphorylation of Na,K-ATPase by protein kinases. Sites, susceptibility, and consequences
26. Phosphorylation of Na,K-ATPase by protein kinase C at Ser18 occurs in intact cells but does not result in direct inhibition of ATP hydrolysis
27. Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the enzyme
28. Cytoplasmic regions of the alpha subunit of the sodium pump involved in modulating the Na,K-ATPase reaction
29. Subunit interactions in the sodium pump
30. Physiology and pharmacology of endogenous digitalis-like factors
31. Evidence of an endogenous ouabain-like immunoreactive compound with digitalis-like properties in the human
32. Purification of an endogenous digitalis-like factor from human plasma for structural analysis
33. Ouabain, digitalis-like factors and hypertension
34. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: Nanogram scale CD structural analysis
35. Identification of digitalis-like compounds in human cataractous lenses
36. Syntheses of (14 beta,15 beta,16 beta,17 alpha)- and (14 beta,15 alpha,16 alpha,17 alpha)-1,3,5(10)-estratriene-2,3,14,15,16,17-hexaols, possible candidates for the Inagami-Tamura endogenous digitalis-like factor, and their activity
37. +)adenosinetriphosphatase of nerve ending membranes: Action of norepinephrine and a soluble factor
38. +-ATPase inhibition by brain endobains
39. +-ATPase inhibitors
40. +)-activated enzyme system
41. Any of several lysines can react with 5'-isothiocyanatofluorescein to inactivate sodium and potassium ion activated adenosinetriphosphatase
42. The reaction of sulfhydryl groups of sodium and potassium ion-activated adenosine triphosphatase with N-ethylmaleimide
43. +) activated ATPase, XLI: Effects of N-ethylmaleimide on overall and partial reactions
44. +)-ATPase
45. Na,K,-ATPase: Functional and structural modifications induced by mercurials
46. +-ATPase
47. Kinetic parameters of Na/K-ATPase modified by free radicals in vitro and in vivo
48. Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: Comparison of signal intensity with changes in brain water and Na + ,K(+)-ATPase activity
49. Na/K-ATPase and oxidative stress
50. Na-K-ATPase: Inactivation and degradation induced by oxygen radicals
51. Oxygen-free radicals directly attack the ATP binding site of the cardiac Na + ,K(+)-ATPase
52. 4-Hydroxynonenal interaction with rhodopsin
53. Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product
54. Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in thymocytes as an effective secondary antioxidative defense mechanism
55. Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages
56. The conversion of carotene to vitamin A (Thomas Moore, 1930)
57. Activation of stress signaling pathways by the end product of lipid peroxidation: 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production